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Autophagy has been implicated as a component of
host defense, but the significance of antimicrobial
autophagy in vivo and the mechanism by which it is
regulated during infection are poorly defined. Here
we found that antiviral autophagy was conserved in
flies and mammals during infection with Rift Valley
fever virus (RVFV), a mosquito-borne virus that
causes disease in humans and livestock. In
Drosophila, Toll-7 limited RVFV replication and
mortality through activation of autophagy. RVFV
infection also elicited autophagy in mouse and hu-
man cells, and viral replication was increased in the
absence of autophagy genes. The mammalian
Toll-like receptor adaptor, MyD88, was required for
anti-RVFV autophagy, revealing an evolutionarily
conserved requirement for pattern-recognition re-
ceptors in antiviral autophagy. Pharmacologic acti-
vation of autophagy inhibited RVFV infection in
mammalian cells, including primary hepatocytes
and neurons. Thus, autophagy modulation might be
an effective strategy for treating RVFV infection,
which lacks approved vaccines and therapeutics.
INTRODUCTION
Autophagy is a fundamental process that mediates the break-
down of cytoplasmic material and is conserved from yeast to
humans (Mizushima and Komatsu, 2011). As an adaptive
response to cellular stress such as starvation, autophagy in-
volves the formation of double-membrane vesicles that degrade
the engulfed content to recycle nutrients (Lum et al., 2005). In
addition to controlling this bulk degradation program, autophagy
genes have also been co-opted by the innate immune system to
orchestrate cell-autonomous antimicrobial responses againstdiverse pathogens, including viruses (Deretic and Levine, 2009;
Levine et al., 2011). For example, in mammals, autophagy re-
stricts the replication or pathogenesis of Herpes simplex virus
type 1 (HSV-1), Sindbis virus (SINV), and Chikungunya virus
(CHIKV) (Joubert et al., 2012; Leib et al., 2009; Orvedahl et al.,
2010). Thus, pharmacological autophagy manipulation has
been proposed as an attractive strategy for treating viral infec-
tion, as well as other diseases including neurodegenerative dis-
orders in which pathogenic protein aggregates are cleared by
autophagy (Rubinsztein et al., 2012; Shoji-Kawata et al., 2013).
Nevertheless, a better understanding of how autophagy is regu-
lated during infection is critical to harness this pathway for
therapeutic purposes.
Emerging data suggest that pattern-recognition receptors
(PRRs) can regulate autophagy activation. These receptors
detect conserved microbial signatures known as pathogen-
associated molecular patterns (PAMPs) to elicit protective
effector responses (Akira et al., 2006). Viruses can be recognized
at the cell surface or in endosomal compartments by Toll-like
receptors (TLRs), which were originally identified through homol-
ogy to Drosophila Toll (Lemaitre et al., 1996; Uematsu and Akira,
2006). Intracellular sensors such as retinoic acid-inducible
gene-1 (RIG-I) and melanoma differentiation-associated protein
5 (MDA-5), collectively termed RIG-I-like receptors (RLRs), can
also detect viral nucleic acids in the cytoplasm (Loo and Gale,
2011). Interestingly, canonical ligands for several TLRs induce
autophagy in macrophages (Campbell and Spector, 2012; Del-
gado et al., 2008; Shi and Kehrl, 2008; Xu et al., 2007). However,
the role of PRR-mediated autophagy in mammals, across
diverse cell types and during viral infection, has remained largely
unexplored.
Taking advantage of Drosophila, recent studies provided crit-
ical insights into the significance of this PRR-autophagy axis in
host defense (Nakamoto et al., 2012; Yano et al., 2008). In flies,
autophagy is essential for controlling Vesicular stomatitis virus
(VSV) replication and limiting host lethality (Shelly et al., 2009).
Toll-7 is the PRR that recognizes VSV to trigger antiviral auto-
phagy and is rapidly induced transcriptionally by infection, along
with several other Toll receptors (Nakamoto et al., 2012; Xu et al.,Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc. 51
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Figure 1. Toll-7 Restricts RVFV Infection in
Adult Flies
(A) Survival of RVFV-infected Toll-7 mutant flies
(Toll-7 null: Df(2R)BSC22/Toll-7g1-5) or sibling
controls (Toll-7 heterozygous: Df(2R)BSC22/+,
+/Toll-7g1-5). Mean ± SE; p < 0.001, log-rank test.
(B) Viral titers from RVFV-infected flies as
measured by plaque assay 3 dpi. Mean ± SD; *p <
0.05, Student’s t test.
(C) RNA blot for RVFV RNA 6 dpi.
(D) Fold increase in RVFV S segment genomic RNA
and N mRNA 6 dpi normalized to Df(2R)BSC22/+
control. Mean ± SE; *p < 0.01, Student’s t test.
(E)Survival ofRVFV-infectedToll-7-overexpressing
flies (hs-Gal4 > UAS-Toll-7) and control flies
(hs-Gal4 > +). Mean ± SE; p < 0.02, log-rank test.
(F) RNA blot for RVFV RNA 6 dpi.
(G) Fold decrease in RVFV N mRNA levels 6 dpi.
Mean ± SE; *p < 0.05, Student’s t test.
(H)BiotinylatedRVFVvirions or IgGwere incubated
with Drosophila cells at 4C for 1 hr and precipi-
tated with streptavidin from cell lysates. Bound
proteins were monitored by immunoblot. All data
are representative of three independent experi-
ments. Figure 1, see also Figure S1.
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Antiviral Autophagy against RVFV Is Conserved2012). Yet it remains unclear whether Toll receptors and auto-
phagy restrict other arthropod-borne viruses (arboviruses),
especially those that are more pathogenic in humans, and
whether this TLR-autophagy axis is conserved in mammals dur-
ing infection.
By screening Toll receptor mutant flies, we identified a role for
Toll-7 in controlling the bunyavirus Rift Valley fever virus (RVFV),
a mosquito-transmitted pathogen that causes disease in
humans and livestock (Walter and Barr, 2011). Though RVFV
infection typically causes a self-limiting febrile illness, the liver
is a major target of infection, with50% of infected humans pre-
senting with jaundice. Some patients develop more severe man-
ifestations such as hemorrhagic fever and encephalitis, and
recent outbreaks have been particularly deadly (Ikegami and
Makino, 2011). Livestock are exceptionally susceptible to infec-
tion, and mortality rates approach 100% in newborn animals.
Furthermore, although historically RVFV has been limited to
Sub-Saharan Africa, the virus has recently spread and can be
weaponized. Vaccines and therapeutics are unavailable for
RVFV, necessitating additional insight into the pathogenesis
and immunologic control of the virus.
We found that Toll-7mutant flies aremore susceptible to RVFV
infection as a result of a defect in virus-triggered antiviral auto-
phagy, which is essential for controlling viral replication and sur-52 Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc.vival. The role of antiviral autophagy is
conserved in mammalian cells, because
RVFV infection activated autophagy in
murine and human cells, and loss of
autophagy genes enhanced viral replica-
tion. The mammalian TLR signaling-
adaptor myeloid-differentiation primary
response 88 (MyD88) restricted RVFV
infection and was required for anti-RVFV
autophagy, suggesting a clear parallelwhereby both Drosophila Tolls and mammalian TLRs direct anti-
viral autophagy. Pharmacologic autophagy activation potently
inhibited RVFV infection in mammalian cells, including primary
hepatocytes and neurons, cell types targeted during pathogenic
humanRVFV infection. Therefore, autophagy activationmight be
an effective strategy for treating RVFV and other viral infections,
especially neurotropic and hepatotropic pathogens that target
tissues in which autophagy is highly manipulable.
RESULTS
Toll-7 Restricts RVFV Replication in Adult Flies
Flies encode nine Toll receptors, but their functions during viral
infection have not been comprehensively evaluated. Therefore,
we screened a subset of these receptors (Toll, Toll-2, Toll-6,
Toll-7, Toll-8, Toll-9) for antiviral functions by challenging mutant
flies with RVFV. From these studies, we identified a critical role
for Toll-7 in limiting susceptibility to RVFV infection. Compared
to sibling controls, heteroallelic Toll-7 mutant flies (Df(2R)
BSC22/Toll-7g1-5) that express no Toll-7 (Yagi et al., 2010) ex-
hibited diminished survival and elevated viral titers after infection
with the attenuated MP12 strain of RVFV (Figures 1A and 1B).
Furthermore, loss of Toll-7 increased levels of RVFV RNA
(S segment genomic RNA and N mRNA) (Figures 1C and 1D).
Immunity
Antiviral Autophagy against RVFV Is ConservedThese data suggest that Toll-7 is required for resistance to RVFV
infection in vivo.
Restriction of RVFV replication is specific for Toll-7. Flies lack-
ing Toll-8 showed no change in lifespan, RVFV titers or viral RNA
compared to control flies (see Figures S1A–S1C available on-
line). Likewise, mutants in Toll, Toll-2, Toll-6, and Toll-9 were
not more susceptible to RVFV challenge (Figures S1D–S1G).
Moreover, we observed no change in survival for Toll-7 mutants
infected with Drosophila C virus (DCV), Flockhouse virus (FHV),
or SINV (Figure S1H–S1J), and Toll-7 mutant flies harbored
equivalent amounts of DCV protein compared to sibling controls
(Figure S1K). Toll-7 is also dispensable for antimicrobial peptide
induction after bacterial infection (Yagi et al., 2010). Taken
together, these data reveal that Toll-7 specifically limits viral
replication and mortality in RVFV-challenged flies.
To complement these loss-of-function studies, we next deter-
mined whether Toll-7 overexpression impacts RVFV infection by
using previously characterized flies that express Toll-7 with heat-
shock induction (Nakamoto et al., 2012). Compared to control
flies, Toll-7-overexpressing flies showed modestly enhanced
survival (Figure 1E) and decreased viral RNA (Figures 1F and
1G). In contrast, overexpression of other Toll receptors did not
reduce mortality during RVFV infection (Figure S1L). Further-
more, Toll-7 overexpression did not limit lethality with DCV,
SINV, and FHV infection (Figure S1M; data not shown). Thus,
both loss-of-function and gain-of-function studies demonstrate
that Toll-7 is an essential facet of defense against RVFV infection.
To determine whether Toll-7 functions as a PRR for RVFV, we
prebound biotinylated purified RVFV virions toDrosophila cells in
the cold to allow surface binding but no internalization, and
precipitated the virus using streptavidin. Biotinylated RVFV but
not control immunoglobulin G (IgG) precipitated endogenous
Toll-7, suggesting that RVFV and Toll-7 physically interact at
the cell surface (Figure 1H). Moreover, biotinylated RVFV did
not precipitate Toll, demonstrating specificity (Figure 1H). There-
fore, RVFV particles, which only contain the viral glycoproteins
on the surface, act as functional ligands for Toll-7, and this
recognition is critical for restricting RVFV infection.
Toll-7-Dependent Antiviral Autophagy Is Required
for Host Defense in Flies
We next examined the mechanism by which Toll-7 controls anti-
viral immunity during RVFV infection. Because Toll-7 is required
for VSV-induced antiviral autophagy (Nakamoto et al., 2012), we
hypothesized that RVFV infection engages a similar autophagic
pathway through Toll-7. During autophagy, Atg8-I is conjugated
to a lipidmoiety, and this form (Atg8-II) is recruited to autophago-
somal membranes (Shelly et al., 2009). An elevation in Atg8-II
expression consequently reflects autophagy activation. Com-
pared to uninfected flies, RVFV-infected flies showed increased
Atg8-II, suggesting that RVFV infection induces autophagy (Fig-
ure 2A). In contrast, DCV and SINV infection did not promote
Atg8-II conversion (Figures S2A and S2B). We also monitored
flies that express green fluorescent protein (GFP)-tagged
Atg8a in the adult female fat body, the functional equivalent of
the mammalian liver and a site of arboviral replication, including
RVFV (Deddouche et al., 2008; Shelly et al., 2009) (data not
shown). GFP-Atg8a forms discrete puncta that correspond to
autophagosomes (Scott et al., 2004). While GFP+ puncta werelargely absent in fat bodies from uninfected flies, fat bodies
from RVFV-infected flies showed an increase in cells containing
GFP+ foci (Figures 2B and 2C). Collectively, these results sug-
gest that RVFV infection elicits autophagy in vivo.
To determine whether RVFV-induced autophagy restricts viral
infection, we silenced a core autophagy gene (Atg18) by using
established in vivo RNAi transgenic flies (Shelly et al., 2009).
Compared to sibling controls, Atg18-depleted flies showed
greatly enhanced lethality after RVFV infection (Figure 2D). More-
over, silencing Atg18 and two other core autophagy genes (Atg5
and Atg7) specifically in the fat body significantly increased
amounts of RVFV RNA (Figures 2E and 2F; Figure S2C). There-
fore, autophagy genes are critical for resistance to RVFV infec-
tion in adult flies.
We next tested the role of Toll-7 in controlling RVFV-induced
autophagy. While flies heterozygous for Toll-7 exhibited an in-
crease in Atg8-II protein after RVFV infection, Atg8-II induction
was abrogated in Toll-7 mutant flies, suggesting that Toll-7 is
required for autophagy activation in response to RVFV infection
(Figure 2G). Conversely, Toll-7 overexpression enhanced the
increase in Atg8-II after infection, demonstrating that Toll-7
expression positively correlates with RVFV-elicited autophagy
activation (Figure 2H).
VSV infection in Drosophila attenuates PI3K-Akt signaling,
which activates the antiviral autophagy program (Shelly et al.,
2009). To evaluate whether RVFV infection represses this path-
way, we monitored phospho-Akt expression. Because resting
phospho-Akt was not detectable, we pretreated flies with insulin
to increase basal phospho-Akt and challenged them with RVFV.
Under these conditions, RVFV-infected flies showed reduced
phospho-Akt compared to uninfected flies with no decrease
in total Akt (Figure 2I), demonstrating that RVFV infection also
inhibits Akt signaling to regulate antiviral autophagy in vivo.
Given that Toll-7-dependent autophagy restricts RVFV repli-
cation, we next determined whether pharmacologic autophagy
activation protects against infection. Because Tor inhibits auto-
phagy, drugs that inhibit Tor (such as rapamycin) are classically
used to activate autophagy. We fed flies 100 mM rapamycin, a
dose that has been used previously, which activated autophagy
as shown by increased Atg8-II conversion (Figure S2D). Lower
amounts of viral RNA were detected in rapamycin-fed flies
compared to controls (Figures 2J and 2K). We next determined
whether pharmacologically-induced autophagy could suppress
the increased virus replication in Toll-7 mutant flies. Again,
vehicle-fed Toll-7 mutant flies showed increased amounts of
viral RNA compared to sibling controls (Figure 2L). Rapamycin
treatment of Toll-7mutants reduced viral RNA to amounts similar
to those detected in control flies. Thus, rapamycin treatment
protects against RVFV infection and bypasses the requirement
for Toll-7 in limiting virus replication. Together, these data sug-
gest that Toll-7 orchestrates a protective antiviral autophagy
response during RVFV infection in vivo.
Autophagy-Mediated Antiviral Defense against RVFV
Is Conserved in Mammalian Cells
VSV can induce autophagy in murine and human cell lines, as
well as in mouse macrophages and plasmacytoid dendritic cells
(Lee et al., 2007; Tal et al., 2009). Despite this robust activation,
autophagy inhibition does not result in increased VSVImmunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc. 53
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Antiviral Autophagy against RVFV Is Conservedreplication, which has been attributed to the role of autophagy in
attenuating RLR-signaling and thus Type I interferon (IFN-I) pro-
duction. However, a role for autophagy in RVFV infection of
mammalian cells has not been explored.
To determine whether autophagy restricts RVFV infection in
murine cells, we examined mouse embryonic fibroblasts
(MEFs) genetically null for Atg5, an essential and conserved
autophagy gene (Kuma et al., 2004). As expected, Atg5/
MEFs were deficient in processing of LC3 (the mammalian
Atg8 homolog) in response to rapamycin and chloroquine, which
inhibits late stages of autophagy and allows for LC3-II accumu-
lation (Figure 3A). Compared to wild-type (WT) cells, Atg5/
MEFs exhibited an increase in RVFV titers by plaque assay (Fig-
ure 3B) and RVFV protein by immunofluorescence (Figures 3D
and 3F). In contrast, we observed no difference in VSV replica-
tion (Figures 3C, 3D, and 3F). Thus, Atg5 specifically controls
RVFV infection in murine cells.
Because Atg5 is required for canonical autophagy, we as-
sessed whether RVFV infection induces autophagy in MEFs.
RVFV infection resulted in the accumulation of processed
LC3-II in WT but not Atg5/MEFs, suggesting that RVFV infec-
tion elicits Atg5-dependent autophagy (Figure 3G). Next, we
monitored expression of the autophagy adaptor p62, which re-
cruits cytoplasmic components to autophagosomes and is
consequently degraded. Therefore, a decrease in p62 expres-
sion denotes flux through the autophagy pathway (Mizushima
et al., 2010). We found that RVFV infection reduced p62 protein
expression in WT MEFs, and this decrease was not observed in
Atg5/ MEFs (Figure 3H). UV-inactivated virus also decreased
p62 protein, demonstrating that RVFV-activated autophagy is
stimulated by a component of the incoming virions, and that
the induction cannot be attributed to viral replication products
or indirect effects due to altered cellular demands during
infection (Figure 3I). MEFs incubated with UV-inactivated virus
showed substantially reduced phospho-Akt without decreased
total Akt, suggesting conserved regulation of antiviral autophagy
by the Akt pathway in both flies and mammals (Figure 3J).
Together, these data show that autophagy is activated in
MEFs to defend against RVFV infection.
Autophagy Genes Restrict RVFV Replication in Human
Cells
We next assessed whether RVFV infection activates autophagy
in a human osteosarcoma cell line (U2OS cells). We monitoredFigure 2. Toll-7 Is Required for RVFV-Induced Autophagy
(A) WT flies (w1118) were infected with RVFV, and Atg8 expression was monitore
(B) Fat body images from uninfected or RVFV-challenged flies expressing GFP-A
puncta in an infected animal. Scale bar represents 10 mM.
(C) Percent of fat body cells containing GFP-Atg8a puncta from uninfected or RV
(D) Survival of RVFV-infected Atg18-silenced flies (Act-Gal4 > UAS-Atg18 IR) or
(E) Representative RNA blot of RVFV RNA from flies depleted of Atg18 in the fat
(F) Fold increase in RVFV RNA in Atg18-silenced flies. Mean ± SE; **p < 0.01, St
(G) Atg8 immunoblot from uninfected or RVFV-infected Toll-7 mutant or control
(H) Atg8 immunoblot from uninfected or RVFV-challenged Toll-7-overexpressing
PBS, and Akt activity was monitored by immunoblot 3 dpi.
(J) RNA blot for RVFV RNA from flies fed either rapamycin (100 mM) (RAPA) or ve
(K) Fold decrease in viral RNA with rapamycin treatment. Mean ± SE; *p < 0.05,
(L) RNA blot for RVFV RNA 6 dpi from Toll-7 mutant or control flies fed either ra
experiments. Figure 2, see also Figure S2.autophagy activation by examining U2OS cells stably expressing
a mCherry-GFP-tagged LC3 reporter; the GFP tag is acid-sensi-
tive, whereas the mCherry tag is acid-insensitive, and thus
mCherry+GFP+ puncta represent early autophagosomes,
whereas mCherry+GFP puncta represent autolysosomes.
LC3 puncta accumulate upon treatment with rapamycin and
chloroquine, with chloroquine primarily leading to mCherry+
GFP+ puncta due to a block of autophagosomal acidifi-
cation (Figures S3A and S3B). We observed an increase in LC3
puncta (mCherry+) after RVFV infection (Figures 4A and 4B), sug-
gesting that RVFV infection induces autophagy. Furthermore,
UV-inactivated RVFV also elicited an increase an LC3 puncta,
which were preferentially mCherry+GFP, consistent with
mature autolysosomes (Figures 4A and 4B; Figure S3B).
Moreover, RVFV infection decreased p62 protein (Figures 4C
and 4D), further indicating that RVFV activates autophagy in
human cells.
To define the importance of autophagy activation during infec-
tion, we silenced the autophagy genes Atg5, Atg7, and Beclin 1
by using small interfering RNA (siRNA), which reduced protein
expression (Figure 4E) and inhibited LC3-II accumulation with
rapamycin or chloroquine treatment (Figures S3C and S3D).
Cells treated with siRNAs against Atg5, Atg7, and Beclin 1 ex-
hibited elevated viral RNA levels after RVFV infection (Figures
4F and 4H). siRNA-mediated silencing of Atg13 and Fip200,
members of the autophagic preinitiation complex, also
increased viral RNA (Figures 4G and 4H). These data show that
multiple stages of the core autophagy pathway are required for
antiviral defense against RVFV from flies to humans.
TRAF6 and MyD88 Restrict RVFV Infection and Promote
Antiviral Autophagy
The pathways that control autophagy downstream of viral recog-
nition are not fully characterized. Because Drosophila Toll-7 rec-
ognizes RVFV to activate antiviral autophagy, we postulated that
a PRR-linked signaling pathway is required for anti-RVFV auto-
phagy in mammals. We first tested the role of cytosolic RLRs,
which detect viral RNA species such as the 50-triphosphate on
RVFV genomic RNAs (Habjan et al., 2008), by examining cells
lacking the common signaling adaptor mitochondrial antiviral-
signaling protein (MAVS) (Dixit et al., 2010). Consistent with a
known role for RIG-I in sensing VSV (Kato et al., 2005),MAVS/
MEFs demonstrated increased VSV titers (Figure S4A). Perhaps
surprisingly, we found no difference in RVFV titers betweend by immunoblot 3 dpi.
tg8a (YP1-Gal4 > UAS-GFP-Atg8a). The arrow indicates a cell with GFP-Atg8a
FV-infected flies. Mean ± SD; **p < 0.01, Student’s t test.
control flies (+ > UAS-Atg18 IR). Mean ± SE; p < 0.001, log-rank test.
body (YP1-Gal4 > Atg18 IR) or control flies 6 dpi.
udent’s t test.
flies.
or control flies. I. Flies (hs > +) were challenged with insulin and either RVFV or
hicle control (ethanol, ETOH) 6 dpi.
Student’s t test.
pamycin or ethanol. All data are representative of at least three independent
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Figure 3. Atg5 Limits RVFV Replication in Mammalian Cells
(A) WT and Atg5/ MEFs were treated with rapamycin (RAPA, 1 mM) or chloroquine (CHQ, 20 mM) for 6 hr and monitored for LC3 expression by immunoblot.
(B and C) RVFV (B) or VSV (C) was titered on WT or Atg5/ MEFs by plaque assay. Mean ± SD; *p < 0.05, Student’s t test.
(D) Immunofluorescence images of WT or Atg5/ MEFs infected with RVFV (16 hr) or VSV (12 hr).
(E and F) Quantification of the percentage of RVFV-infected (E) or VSV-infected (F) cells normalized to the WT control. Mean ± SD; *p < 0.05, Student’s t test.
(G) Immunoblot for LC3 in uninfected or RVFV-infected WT and Atg5/ MEFs 8 hpi.
(H) Immunoblot for p62 in WT or Atg5/ MEFs 12 hpi.
(I) Immunoblot for p62 in WT MEFs incubated with UV-inactivated RVFV for 16 hr.
(J) Immunoblot for phospho-Akt and total Akt from WT MEFs incubated with UV-inactivated RVFV for 8 hr. All data represent three independent experiments.
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Antiviral Autophagy against RVFV Is ConservedMAVS/ and WT MEFs, suggesting that RLRs are dispensable
for restricting RVFV infection in this cell type (Figure S4B). Similar
results were found when monitoring VSV and RVFV infection by
immunofluorescence (Figures S4C–S4E). In addition, MAVS was
dispensable for RVFV-induced p62 degradation (Figure S4F).We
also examined the role of TANK-binding kinase-1 (TBK1), which
functions downstream of RLRs (and certain endosomal TLRs56 Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc.such as TLR3) and is essential for antimicrobial autophagy
against Mycobacterium tuberculosis (Fitzgerald et al., 2003;
Watson et al., 2012). TBK1/ MEFs exhibited increased infec-
tion with VSV but not RVFV, as well as normal RVFV-associated
p62 degradation (Figures S4G–S4L). Consequently, neither
TBK1 nor MAVS is required for RVFV-induced antiviral auto-
phagy in MEFs.
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Figure 4. Autophagy Genes Restrict RVFV Infection in Human Cells
(A) Representative image of human U2OS cells stably expressing a mCherry-GFP-LC3 reporter either mock infected or infected with RVFV (MOI 10) or
UV-inactivated RVFV at 12 hpi. mCherry puncta represent total autophagosomes.
(B) Quantification of the average mCherry+ LC3 puncta per cell. Mean ± SE; *p < 0.05, Student’s t test.
(C) U2OS cells were infected with RVFV at the indicated MOI and p62 expression was assessed by immunoblot 18 hpi.
(D) Average p62 protein levels normalized to tubulin from uninfected or RVFV-infected U2OS cells. Mean ± SE; *p < 0.05, Student’s t test.
(E) Immunoblot from U2OS cells transfected with the indicated siRNAs.
(F and G) RNA blot for RVFV RNA from U2OS cells transfected with the indicated siRNAs 16 hpi.
(H) Average fold increase in RVFV RNA by RNA quantification. Mean ± SE; *p < 0.05, Student’s t test. All data represent three independent experiments. Figure 4,
see also Figure S3.
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Antiviral Autophagy against RVFV Is ConservedTLRs recognize viruses at the plasma membrane or in endo-
somes and TLR ligands activate autophagy in macrophages
(Delgado et al., 2008; Xu et al., 2007). Because Toll-7 is
required for RVFV-induced autophagy in flies, we examined
whether TLRs regulate RVFV-induced autophagy. TLRs signal
through two Toll-IL-1 receptor (TIR) domain-containing
adapters, MyD88 and TRIF (O’Neill and Bowie, 2007). To
determine whether either TIR adaptor restricts RVFV infection,
we silenced MyD88 and TRIF in U2OS cells by using siRNAs
and verified knockdown by immunoblot (Figure 5A). MyD88
silencing increased RVFV infection by immunofluorescencesimilar to Beclin 1 knockdown (Figures 5B and 5C). In
contrast, we found no change in infection with TRIF depletion,
suggesting that MyD88, but not TRIF, mediates cell-intrinsic
immunity to RVFV (Figures 5B and 5C). MyD88-silenced cells
also demonstrated increased RVFV RNA (Figures 5D and 5E).
Consistent with our results in human cells, RVFV-challenged
Myd88/ MEFs (Tal et al., 2009) showed a significant
increase in viral titers, similar to the increase observed in
Atg5/ MEFs (10-fold, Figure 5F). These data implicate
MyD88 as a critical component in mammalian host defense
against RVFV.Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc. 57
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Antiviral Autophagy against RVFV Is ConservedRVFV infection increased the percentage of U2OS cells con-
tainingLC3puncta, andsilencingofAtg5abrogated this response
(Figures 5G and 5H). Whereas TRIF was dispensable for RVFV-
triggered autophagy, MyD88-silenced cells showed a decrease
in RVFV-induced LC3 puncta compared to control cells (Fig-
ure5H).Moreover,RVFV-infectedMyd88/MEFsdemonstrated
impaired LC3-II accumulation and p62 degradation (Figures 5I
and 5J). This defect was not due to a general requirement for
MyD88 in autophagy because MyD88 silencing had no impact
on LC3-II accumulation with rapamycin or chloroquine treatment
(Figure S4M). These data suggest that antiviral autophagy against
RVFV is MyD88-dependent in both human and mouse cells.
Previous studies have shown that the E3 ubiquitin ligase tumor
necrosis factor receptor-associated factor 6 (TRAF6) regulates
LPS-induced autophagy, which partly depended on MyD88
(Shi and Kehrl, 2008, 2010). Therefore, we tested the require-
ment for TRAF6 in RVFV-elicited autophagy by using previously
validated reagents (Sun et al., 2004). RNAi-mediated depletion of
TRAF6was efficient in U2OS cells andmarkedly increased RVFV
protein and RNA (Figures 5K and 5L; Figure S4N). TRAF6 knock-
down also impaired UV-RVFV-induced LC3 puncta accumula-
tion similar to Atg5 and MyD88 silencing (Figure 5M). Thus,
TRAF6, which is known to act downstream of MyD88 in TLR
signaling pathways, is necessary for activating autophagy to
control RVFV replication in human cells.
To test for evolutionary conservation, we next assessed the
role of Drosophila Traf6, which has been implicated in canonical
Toll signaling (Shen et al., 2001), although other immune
functions remain to be determined. We challenged previously
characterized Traf6 mutant flies (dTraf6Ex1/dTraf6Ex1) (Cha
et al., 2003) or heterozygous controls with RVFV and found
that Traf6 mutant flies showed significantly increased viral
RNA levels, indicating that Traf6 controls RVFV infection in vivo
(Figure 5N; Figure S4O). Further, Traf6 mutants showed
impaired autophagy activation during RVFV infection as as-
sessed by Atg8 immunoblot (Figure 5O). Taken together, these
data demonstrate a requirement for TRAF6 in antiviral auto-
phagy in both flies and mammals, revealing additional con-
served components of this innate defense pathway.Figure 5. TRAF6 and Mammalian MyD88 Restrict RVFV Replication an
(A) Immunoblot of MyD88 and TRIF from U2OS cells transfected with the indicat
(B) Representative immunofluorescence images of U2OS cells transfected with t
(C) Average percentage of infected cells normalized to control. Mean ± SD; *p <
(D) RNA blot for RVFV RNA from U2OS cells transfected with MyD88-specific siR
(E) Quantification of RVFV RNA from (D). Mean ± SE; *p < 0.05, Student’s t test.
(F) Plaque assays with RVFV were performed on Myd88/ or WT MEFs. Mean ±
(G) Representative images of siRNA-transfected U2OS cells expressing a mC
mCherry puncta are shown.
(H) Quantification of the percentage of cells with at least 5 LC3-positive puncta pe
test.
(I) LC3 immunoblot of Myd88/ or WT MEFs infected with RVFV 12 hpi.
(J) p62 immunoblot of Myd88/ or WT MEFs infected with RVFV 16 hpi.
(K) Immunoblot for RVFV Gn and TRAF6 from siRNA-transfected U2OS infected
(L) Fold increase in RVFV S segment RNA quantified by RNA blot. Mean ± SE; *p
(M) Average percentage of cells with at least 5 LC3 puncta from mCherry-GFP
UV-inactivated RVFV for 12 hr. Mean ± SE; *p < 0.05 compared to siCon UV-RV
(N) Fold increase in RVFV S segment RNA from Traf6/ flies (dTraf6Ex1/dTraf6Ex1
Student’s t test.
(O) Atg8 immunoblot from uninfected or RVFV-infected flies 3 dpi. One represe
sentative of three independent experiments unless otherwise indicated. Figure 5Autophagy-Activating Drugs Protect against RVFV
Infection in Mammalian Cells
There are no specific therapeutics against RVFV infection, lead-
ing to high mortality during outbreaks (Ikegami and Makino,
2011). Because autophagy genes restrict RVFV replication,
drugs that activate this pathway might offer a strategy to treat
RVFV infection in humans. In addition to testing rapamycin, we
evaluated the protective effect of small molecule enhancer of
rapamycin (SMER)28, a recently developed mTor-independent
autophagy inducer (Sarkar et al., 2007). As expected, treatment
of U2OS cells with rapamycin or SMER28-activated autophagy
as measured by increased LC3 puncta formation that was
dependent on Atg5 (Figures S5A and S5B).
To determine whether autophagy-activating drugs protect
against RVFV infection, we pretreated MEFs with rapamycin or
SMER28 and infected with RVFV. Both drugs dramatically
reduced the percentage of RVFV-infected cells in a dose-depen-
dentmanner (Figure 6A–6C) with IC50 valueswithin previously re-
ported ranges (Noh et al., 2004; Sarkar et al., 2007). Both drugs
also protected against RVFV infection in U2OS cells (Figures 6D–
6F), and this antiviral effect was specific, because we observed
no inhibition of VSV or SINV infection, consistent with previous
findings that VSV and SINV replication is insensitive to rapamy-
cin treatment (Figures 6G and 6H) (Connor and Lyles, 2002; Mo-
hankumar et al., 2011). Thus, these data suggest that chemical
activation of autophagy limits RVFV in mammalian cells.
We next asked whether these drugs play a protective role in
primary cells from tissues targeted by RVFV during natural infec-
tion. RVFV is highly hepatotropic in humans and mice, and infec-
tion can progress to fulminant hepatitis (Ikegami and Makino,
2011). RVFV infection induced autophagy in primary mouse
hepatocytes as measured by increased LC3-II and decreased
p62 expression (Figure 7A). Strikingly, both rapamycin and
SMER28 treatment dramatically reduced viral RNA (Figure 7B),
indicating that autophagy inducers have powerful antiviral activity
in hepatocytes. We observed no increase in induction of the IFN-
stimulatedgene Isg56 in rapamycinorSMER28 treatedcells; thus,
the protective effect of autophagy-activating drugs likely cannot
be explained by an exaggerated IFN-I response (Figure 7C).d Regulate Antiviral Autophagy
ed siRNAs.
he indicated siRNAs and infected with RVFV at 16 hpi (MOI 0.1).
0.05, Student’s t test.
NA or control siRNA and infected with RVFV (MOI 0.3) 16 hpi.
SD; *p < 0.05, Student’s t test.
herry-GFP-LC3 reporter and left uninfected or infected with RVFV (MOI 10).
r cell. Mean ± SE; *p < 0.05 compared to siCon RVFV-infected cells, Student’s t
with RVFV 16 hpi.
< 0.05, Student’s t test.
-LC3 U2OS cells transfected with the indicated siRNAs and incubated with
FV treated cells, Student’s t test.
) or control Traf6+/ flies as quantified by RNA blot 6 dpi. Mean ± SE; *p < 0.05,
ntative blot from two independent experiments is shown. All data are repre-
, see also Figure S4.
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Figure 6. Autophagy-Activating Drugs Protect against RVFV Infection in Mammalian Cells
(A) MEFs were pretreated with rapamycin (1 mM), SMER28 (50 mM), or vehicle control (ethanol) for 1 hr and infected with RVFV (MOI 1). Infection wasmonitored by
immunofluorescence.
(B and C) Dose-response curve for RVFV infection of MEFs treated with the indicated concentrations of rapamycin (B) or SMER28 (C). Percent infection was
normalized to vehicle control-treated cells.
(D) Representative immunofluorescence image of U2OS cells pretreated with rapamycin or SMER28 and infected with RVFV at 16 hpi.
(E and F) Dose-response curve for RVFV infection of U2OS treated with the indicated concentrations of rapamycin (E) or SMER28 (F).
(G andH) Dose-response curve for VSV and SINV infection of U2OS treated with the indicated concentrations of rapamycin (G) or SMER28 (H). Data showmean ±
SE for three independent experiments. Figure 6, see also Figure S5.
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Antiviral Autophagy against RVFV Is ConservedSome RVFV-infected humans develop severe neurological
disorders and encephalitis, suggesting that RVFV is neuroinva-
sive (Ikegami and Makino, 2011). Moreover, mice that survive
acute RVFV infection can develop encephalitis similar to hu-
mans, and viral antigen can be detected in a wide variety of
neuronal cell types in the brain (Ross et al., 2012). We conse-60 Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc.quently asked whether autophagy activation inhibits RVFV
infection in primary rat mixed neuroglial cultures. Both
SMER28 and rapamycin induced autophagy in neuronal cul-
tures as shown by increased LC3-II accumulation and p62
degradation (Figure 7D). Whereas the majority of neuronal cells
were infected in control cultures, SMER28-treated cells were
A B C
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Figure 7. Autophagy Inducers Inhibit RVFV Infection in Primary Mouse Hepatocytes and Rat Neurons
(A) Primary mouse hepatocytes were infected with RVFV (MOI 5) and protein was isolated at the indicated time points after infection to assess p62 and LC3
expression by immunoblot. Data are representative of two independent experiments.
(B) RVFV RNA levels from primary mouse hepatocytes pretreated with SMER28 or rapamycin and infected with RVFV (MOI 1) for 20 hr as determined by qRT-
PCR. Data are representative of two independent experiments.
(C) Isg56 mRNA expression quantified by qRT-PCR from RVFV-infected mouse hepatocytes treated with the indicated drugs or vehicle control at 20 hpi.
(D) Primary rat neuronal cultures were infected with RVFV for the indicated times (MOI 1) or treated with rapamycin (1 mM) or SMER28 (50 mM) for 16 hr.
Immunoblot analysis of LC3 and p62 expression is shown. Data are representative of two independent experiments.
(E) Primary rat neuronal cultures were pretreated with SMER28 or vehicle control for 1 hr and infected with RVFV (MOI 0.1) for 22 hr. Infection was assessed by
immunofluorescence.
(F) Fold decrease in the percent of RVFV-infected rat neuronal cells with SMER28 treatment. Mean ± SE for three independent experiments; *p < 0.05, Student’s t
test.
(G) Immunofluorescence of RVFV and neurons (MAP2-positive cells) from RVFV-infected neuronal cultures pretreated with SMER28 or vehicle control showing
preferential protection of neurons with SMER28 treatment.
(H) RVFV RNA was quantified by qRT-PCR from infected cells pretreated with SMER28 or rapamycin at 22 hpi. Mean ± SE for three independent experiments
normalized to ETOH control; *p < 0.05, Student’s t test.
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Antiviral Autophagy against RVFV Is Conservedlargely protected (Figures 7E and 7F). Costaining for microtu-
bule-associated protein 2 (MAP2), a neuronal differentiation
marker, revealed that whereas neurons were efficiently infected
by RVFV in control cultures, nonneuronal cells were dispropor-
tionately infected in SMER28 cultures, indicating that the
SMER28 is particularly protective in neurons (Figure 7G). Thisinhibition was also observed when monitoring viral RNA,
because SMER28 treatment resulted in a 95% reduction in
RVFV RNA (Figure 7H). We also observed inhibition of RVFV
infection with rapamycin treatment, albeit more modestly (Fig-
ure 7H). Notably, RVFV infection activated autophagy in neuro-
glial cultures as shown by robust p62 degradation and elevatedImmunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc. 61
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Antiviral Autophagy against RVFV Is ConservedLC3-II levels (Figure 7D), suggesting that autophagy activation
is a normal response to RVFV infection in neuronal cells.
Collectively, these data suggest that pharmacologic activation
of autophagy protects hepatocytes and neurons against
RVFV infection and might be a promising treatment strategy
for RVFV-induced hepatitis and encephalitis.
DISCUSSION
Autophagy is an ancient host response to starvation that has
emerged as an important facet of the innate immune arsenal.
We found that in both flies and mammals, autophagy genes
restrict the replication of RVFV, a medically and agriculturally
relevant arbovirus for which there is no effective treatment or
vaccine. Intervention with autophagy-activating drugs potently
blocks infection. Therefore, this study provides insight into the
mechanisms regulating antiviral autophagy and offers a potential
avenue for developing RVFV-directed treatments.
By screening the Drosophila Tolls, we have extended the anti-
viral Toll receptor-autophagy axis to RVFV. Toll-7 mutant flies
succumb to RVFV infection, whereas flies that overexpress
Toll-7 are protected. Moreover, Toll-7 interacted with purified
RVFV virions, suggesting that Toll-7 likely recognizes surface-
exposed RVFV glycoproteins, similar to the autophagy-inducing
glycoprotein PAMP on VSV (Nakamoto et al., 2012). Although we
found no role for other Toll receptors in RVFV infection, they
might function in unknown contexts, perhaps with distinct path-
ogens. Indeed, a recent study showed that Toll-8 negatively reg-
ulates antimicrobial peptide gene expression in larval respiratory
epithelia (Akhouayri et al., 2011). Together, these findings sug-
gest that Toll receptors evolved as critical components of host
defense and immune regulatory pathways.
We found that Toll-7 restricts RVFV by activating autophagy,
because Toll-7 is necessary for RVFV-induced autophagy
in vivo, and silencing of autophagy genes leads to increased
mortality and viral replication. Furthermore, antiviral autophagy
against RVFV infection is conserved in mammals. RVFV trig-
gered autophagy in mouse, rat, and human cells, and its replica-
tion was enhanced by deficiency of core autophagy genes in
MEFs and U2OS cells. Although diverse viruses can trigger
autophagy, the ability of autophagy to limit viral replication is
complicated. For example, neuron-specific deletion of Atg5 in-
creases lethality after SINV infection, but viral titers are not
generally affected, indicating that autophagy does not restrict
SINV replication per se (Orvedahl et al., 2010). WT HSV-1 is
also not normally restricted by autophagy because it encodes
a virulence factor ICP34.5 that inhibits autophagy (Orvedahl
et al., 2007; Tallo´czy et al., 2002). Proviral and antiviral functions
have also been reported for autophagy in CHIKV infection (Jou-
bert et al., 2012; Krejbich-Trotot et al., 2011). Thus, our data
suggest that autophagy might play a more direct and evolution-
arily conserved role in restricting RVFV replication than other
viruses.
Recent studies propose that autophagy genes can function
outside of canonical autophagy. For example, IFN-g-mediated
mouse norovirus restriction requires the Atg5-Atg12-Atg16L1
complex, but not Atg4B or lysosomal degradation, and Atg5 re-
stricts T. gondii replication without the requirement for autopha-
gosome generation (Hwang et al., 2012; Zhao et al., 2008).62 Immunity 40, 51–65, January 16, 2014 ª2014 Elsevier Inc.Because there are no specific genes for these autophagy-related
processes, their distinction is in part based on the demonstration
that certain ‘‘cassettes’’ of autophagy genes are required while
others are dispensable. We show that genes involved in multiple
stages of autophagy restrict RVFV replication, from the preinitia-
tion complex (i.e., Atg13 and Fip200) to the elongation phase
(i.e., Atg5 and Atg7). Thus, canonical autophagy likely restricts
RVFV infection, although the antiviral mechanism remains to
be clarified.
Relatively little is known about the PRRs and signaling path-
ways that activate antiviral autophagy. Although nucleocapsid-
associated RVFV RNA activates RIG-I, we found no role for the
downstream adaptor MAVS in restricting RVFV infection (Weber
et al., 2013). This differencemight be related to cell-type-specific
functions for autophagy and PRRs. Indeed, MAVS does not
restrict RVFV replication in macrophages even though it regu-
lates IFN-I expression, suggesting that IFN-I alone cannot
explain RVFV control (Ermler et al., 2013). Moreover, RVFV en-
codes an IFN antagonist (NSs), and so other restriction mecha-
nisms besides IFN-I must exist (Bouloy et al., 2001). Our data
provide evidence that perhaps autophagy is the major antiviral
pathway against RVFV in some cell types.
BecauseMAVS does not restrict RVFV replication inMEFs, we
focused on the TLR signaling adapters MyD88 and TRIF. MyD88
but not TRIF was required to restrict RVFV infection and elicit
anti-RVFV autophagy. Thus, TLR-mediated signaling has an
evolutionarily conserved role in directing antiviral autophagy
from flies to mammals. The specific TLR required for RVFV-
induced autophagy remains unknown. U2OS cells express all
TLRs but TLR8, and MEFs express TLRs 1–9 (Kurt-Jones
et al., 2004; Shatz et al., 2012). Given that TRIF and TBK1 do
not restrict RVFV infection, we hypothesize that the auto-
phagy-activating receptor is a plasma membrane TLR like
TLR2 and TLR4, which have been shown to recognize viral gly-
coproteins (Barbalat et al., 2009; Georgel et al., 2007). This
would parallel Drosophila Toll-7, which binds viral particles at
the cell surface. Indeed, the critical role for plasma membrane
TLRs in antimicrobial autophagy is supported by recent findings
that TLR2 is required for Listeria monocytogenes-induced auto-
phagy (Anand et al., 2011). In addition to revealing a requirement
for MyD88 in autophagy activation, our study also suggests an
important cell-intrinsic role for MyD88 and TLRs in host defense
against viruses. Only a few reports have shown a cell-intrinsic
requirement for MyD88 in controlling viral replication, such as
in West Nile virus (WNV) infection of macrophages and certain
types of neurons (Szretter et al., 2010). We propose that
MyD88 has unappreciated functions in cell-intrinsic antiviral im-
munity, such as by controlling autophagy or other IFN-indepen-
dent pathways.
Two additional pathways downstream of virus recognition
regulate antiviral autophagy in flies and mammals. Because
TRAF6 has been associated with LPS-induced autophagy, we
investigated the requirement for TRAF6 during RVFV infection.
Loss of TRAF6 in mammalian cells or flies resulted in increased
viral replication and impaired autophagy activation, revealing a
critical role for TRAF6 in anti-RVFV autophagy. Importantly,
these data show that Drosophila TRAF6 can restrict pathogen
replication in vivo. In Drosophila and mammalian cells, RVFV
infection also led to decreased Akt activation, suggesting that
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Antiviral Autophagy against RVFV Is Conservedthis PRR-TRAF6 signaling axis converges on Akt to regulate anti-
viral autophagy initiation. Taken together, these data demon-
strate deep conservation of anti-RVFV autophagy across
species.
Autophagy modulation has been proposed as a treatment for
diverse human disorders, including cancer, neurodegenerative
disease, and infection. We found that treatment with two auto-
phagy inducers, rapamycin and SMER28, greatly reduced viral
replication in a variety of human and murine cell types, including
primary mouse hepatocytes and rat neurons. Because RVFV tar-
geting of hepatocytes and neurons during natural infection is one
of the main causes of morbidity and mortality, autophagy activa-
tion might be a viable strategy for RVFV intervention in humans
and livestock. These findings are consistent with a recent report
identifying an autophagy-inducing peptide (Tat-Beclin 1) that
limits susceptibility to WNV, SINV, and CHKV in mice (Shoji-Ka-
wata et al., 2013). Although the host-protective mechanism of
Tat-Beclin 1 has not been fully elucidated, the prosurvival effects
of autophagy rather than a direct effect on virus growth might be
involved because autophagy per se does not normally restrict
the replication of these particular viruses (Beatman et al., 2012;
Krejbich-Trotot et al., 2011; Orvedahl et al., 2010; Vandergaast
and Fredericksen, 2012). Because RVFV replication is normally
restricted by autophagy, boosting this processmight be a partic-
ularly effective therapeutic strategy for RVFV infection.
Most studies on infection and immunity have relied on cell lines
or macrophages, but emerging evidence suggests unique func-
tions for autophagy in other cell types. Many of the viruses
restricted by autophagy infect neurons, including SINV and
HSV-1, as well as RVFV identified in this study. Moreover,
some cells rely more heavily on IFN-I-independent mechanisms
to counteract virus infection. This was clearly shown for dorsal
root ganglion neurons, which are less responsive to IFN-I and
use autophagy as a major anti-HSV-1 defense (Yordy and Iwa-
saki, 2012). We also find that autophagy activation limits RVFV
replication in hepatocytes, another cell type that has high basal
autophagy and in which autophagy has not been extensively
studied for its role in antiviral defense. It will be interesting to
determine the relative contribution of IFN-I versus autophagy in
viral control in neurons and hepatocytes during RVFV infection
and whether other viruses that target these organs are suscepti-
ble to antiviral autophagy.
In conclusion, we have taken advantage of the simplified sys-
tem in Drosophila to discover a conserved role for autophagy
genes in restricting RVFV replication in mammals. Toll receptors
or signaling molecules downstream of TLRs (i.e., MyD88) are
necessary for RVFV-induced autophagy in both flies and
mammalian cells, further defining the ancient nature of the anti-
viral autophagy response. These findings help elucidate the
mechanism by which autophagy is triggered during viral infec-
tion and add to the mounting evidence that autophagy activation
might be beneficial for treating infections and other diseases.EXPERIMENTAL PROCEDURES
Adult Fly Infections
Four- to seven-day-old flies were challenged as previously described (Shelly
et al., 2009). For Toll receptor overexpression experiments, flies were heat
shocked at 37C for 1 hr prior to infection and heat shocked every 2 days. Flieswere monitored for mortality or processed at the indicated time points after
infection. For rapamycin feeding, flies were starved for 1 hr, placed on food
supplemented with 100 mM rapamycin or vehicle, and infected the next day.
To monitor Akt activity, we challenged flies with insulin (1 mM) and either
PBS or RVFV as previously described (Shelly et al., 2009).
Viral Infections
Cells were infected with RVFV, SINV, and VSV as previously described for the
indicated times and MOIs (Moser et al., 2012).
Immunofluorescence
Cells were stained as previously described (Shelly et al., 2009). Automated
microscopy (ImageXpressMicro)wasused to imagecellswith at least four sites
per well and three wells per condition, and percent infection was calculated
with MetaXpress image analysis. Neurons and mCherry-GFP-LC3 U2OS cells
grown on coverslips were imaged with a Leica DMI 4000 B fluorescent micro-
scope. MetaXpress software was used to quantify LC3 puncta.
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Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
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